Search results
Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
Zacks via Yahoo Finance Canada· 2 weeks agoShares of Intellia Therapeutics, Inc. NTLA were down 4.5% on Jun 26 after it announced that its...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Finance Canada· 2 weeks agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
Intellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
Zacks via Yahoo Finance Canada· 1 month agoIntellia (NTLA) gains 10% after reporting encouraging long-term efficacy data from the phase I...
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
GuruFocus.com via Yahoo Finance Canada· 2 months agoHelen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX),...
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
GuruFocus.com via Yahoo Finance Canada· 2 months agoOn May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased...
Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)
GuruFocus.com via Yahoo Finance Canada· 2 months agoAnthony Doyle, Chief Financial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased...
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 2 months agoIntellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript May 9, 2024 Intellia...
Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
GuruFocus.com via Yahoo Finance Canada· 2 months agoRevenue: Reported $28.9 million in collaboration revenue for Q1 2024, surpassing the estimated $19.18 million. Net Loss: Recorded a net loss of $107.4 million, below the estimated net loss of ...
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance Canada· 2 months agoIonis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which was...
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 2 months agoParticipants Brett P. Monia; Founder, CEO & Director; Ionis Pharmaceuticals, Inc. D. Wade Walke; SVP of IR; Ionis Pharmaceuticals, Inc. Elizabeth L. Hougen; Executive VP of Finance & CFO; Ionis ...